14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 50 days ( 0 % )
Last Price $0.321 0 %
High/ Low $0.321 - $0.321 0%
Chg 7 Days N/A $0.321 $0.321
Chg 30 Days N/A $0.321 $0.321
Chg 12 mos -76.24 % $1.35 $0.321
Trend - 3 mos -26.02 % Width: 654.17 %
Trend - 12 mos -73.38 % Width: 864.36 %
Pred. range - 3 mos $0.0484 - $0.365 -84.92 % - 13.71 %
Pred. range - 12 mos N/A - $0.122 -100.00 % - -61.95 %
Short MA avg 3 mos Sell Feb 09, 2024 - 53 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Feb 06, 2024 - 56 days
Long MA avg 12 mos Sell Aug 11, 2023 - 178 days
Short/Long MA avg 12 mos Sell Aug 24, 2023 - 169 days
Pivot Short Buy Feb 12, 2024 - 52 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings . InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was ... NVIV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT